[Pharmacological potentiation of the radioprotective action of hypoxic hypoxia].
D008735:5-Methoxytryptamine / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002587:Cesium Isotopes; D002746:Chlorpromazine / Q000494:pharmacology; D004837:Epinephrine / Q000627:therapeutic use; D005720:Gamma Rays; D006632:Histamine / Q000627:therapeutic use; D051379:Mice; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use; D010100:Oxygen; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D014363:Tryptamines / Q000494:pharmacology; D000338:beta-Aminoethyl Isothiourea / Q000627:therapeutic use
D002587:Cesium Isotopes; D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D014363:Tryptamines; D000338:beta-Aminoethyl Isothiourea; D008735:5-Methoxytryptamine; D001285:Atropine; D006632:Histamine; D000109:Acetylcholine; D010100:Oxygen; D002746:Chlorpromazine; D004837:Epinephrine
Farmakologicheskoe potentsirovanie radiozashchitnogo deĭstviia gipoksicheskoĭ gipoksii